The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma
published in: Leukemia
date of publication: 2020-07-14
Cites articles 53
- 2016-09-14
- 2015-04-02
Date
Title
Article - wd:Q97524044